NASDAQ:QTRX Quanterix Q3 2024 Earnings Results & Report $3.16 +0.02 (+0.48%) As of 11:56 AM Eastern This is a fair market value price provided by Massive. Learn more. Quanterix reported Q3 2024 earnings on December 23, 2024. The company reported EPS of -$0.22. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2024Report DateDecember 23, 2024TimeAfter Market Closes Quanterix EPS ResultsActual EPS-$0.22Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersQuanterix Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsQuanterix's Q3 2026 earnings is estimated for Monday, November 9, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesEarnings HistoryCompany Profile Quanterix Q3 2024 Earnings FAQ Did Quanterix beat earnings estimates for Q3 2024? Quanterix (NASDAQ:QTRX) reported earnings of -$0.22 per share for Q3 2024. The report was announced on Monday, December 23, 2024. When is Quanterix's next earnings date? Quanterix's next earnings date is estimated for Monday, November 9, 2026. MarketBeat tracks confirmed and estimated earnings dates for Quanterix on the company's earnings history page. Quanterix Earnings HeadlinesALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchOctober 8, 2026 | marketscreener.comMQuanterix and Innovita Expand IVD Access in China with National Medical Products Administration ApprovalsOctober 7, 2026 | finance.yahoo.comElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11.October 14 at 1:00 AM | Brownstone Research (Ad)Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026September 25, 2026 | markets.ft.comQuanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel DevelopmentSeptember 25, 2026 | marketscreener.comMQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 16, 2026 | businesswire.comSee More Quanterix Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Quanterix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quanterix and other key companies, straight to your email. Email Address About QuanterixQuanterix (NASDAQ:QTRX) (NASDAQ:QTRX) is a life sciences company that develops technologies for detecting and measuring very low concentrations of biomarkers in blood and other biological samples. Its platform is designed to support research and clinical development in areas including neurology, oncology, immunology, infectious diseases and cardiovascular disease. The company’s core technology, Simoa (Single Molecule Array), uses digital immunoassay methods to detect proteins and other biomarkers at levels below the practical range of many conventional laboratory tests. Quanterix offers laboratory instruments such as the HD-X, SR-X and SP-X systems, along with assay kits, consumables, software and related laboratory services. Its products are used by pharmaceutical and biotechnology companies, academic and government researchers, diagnostic developers and clinical laboratories. Founded in 2007 and headquartered in Billerica, Massachusetts, Quanterix serves customers through direct and commercial channels in the United States and internationally. The company has also expanded its offerings through partnerships and acquisitions, including the addition of technologies intended to broaden its biomarker analysis capabilities. Masoud Toloue has served as Quanterix’s president and chief executive officer since January 2024.View Quanterix ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American BusinessTax Credit Turmoil: Why Enphase and SolarEdge Face a Tough RoadSurgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?Venezuela's Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
